Month: July 2020

NEW YORK, July 21, 2020 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that the Oncologic Drugs Advisory Committee (ODAC) of the United States Food and Drug Administration (FDA) has scheduled a meeting on August 13, 2020 to review data supporting the Company’s Biologics License Application (BLA) for approval of RYONCIL™ (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD) in children.There are currently no FDA-approved treatments in the United States for children under 12 with SR-aGVHD, a potentially life-threatening complication of an allogeneic bone marrow transplant for blood cancer. RYONCIL is under Priority Review by the FDA with an action date of September 30, 2020, under the Prescription Drug User Fee Act (PDUFA).The ODAC is an independent panel of...

All amounts in U.S. dollars unless otherwise stated TORONTO, July 21, 2020 (GLOBE NEWSWIRE) — Onex Corporation (“Onex”) (TSX: ONEX) confirms all nominees set forth in the management information circular for its July 21, 2020 Annual Meeting of Shareholders have been elected as directors of the Company.  Detailed results of the vote for each director are set out below.Onex also presented an advisory resolution to shareholders endorsing the Company’s approach to executive compensation, generally referred to as “say-on-pay”.  The Company is pleased to report the advisory resolution passed overwhelmingly with 96.23% support.Finally, Onex shareholders confirmed almost unanimously a by-law adopted by Onex in connection with its acquisition of WestJet in December 2019 related to ensuring Canadian ownership and control of WestJet.About ...

SECOND QUARTER 20201 HIGHLIGHTSGAAP diluted EPS was $0.63, compared to ($0.05) in 1Q20 and $0.37 in 2Q19Core diluted EPS was $0.36 compared to $0.19 in 1Q20 and $0.42 in 2Q19Net interest margin was 2.87%, up 43bps QoQ and 42bps YoYCore net interest margin was 2.85%, up 36bps QoQ and 45bps YoYRecord GAAP net interest income of $48.7 million, up 19.3% QoQ and 21.8% YoYRecord Core net interest income of $49.1 million, up 14.4% QoQ and 20.2% YoYGAAP and core ROAE 13.1% and 7.4%, respectively, compared with (1.0)% and 3.8%, respectively in 1Q20GAAP and core ROAA were 1.0% and 0.6%, respectively, compared with (0.1)% and 0.3%, respectively in 1Q20Loan pipeline remains strong at $310.8 millionProvision for credit losses of $9.6 million, $0.25 after-tax per diluted common share, driven mainly by economic conditions arising from COVID-19 pandemicNet...

CHICAGO, July 21, 2020 (GLOBE NEWSWIRE) — First Midwest Bancorp, Inc. (the “Company” or “First Midwest”), the holding company of First Midwest Bank (the “Bank”), today reported results of operations and financial condition for the second quarter of 2020. Net income applicable to common shares for the second quarter of 2020 was $17.8 million, or $0.16 per share, compared to $19.4 million, or $0.18 per share, for the first quarter of 2020, and $46.6 million, or $0.43 per share, for the second quarter of 2019.Results for the second and first quarters of 2020 were impacted by the COVID-19 pandemic (the “pandemic”) and governmental responses to it, resulting in higher provision for loan losses, as well as lower net interest and noninterest income. In addition, the adoption of the current...

GOLDEN, Colo., July 21, 2020 (GLOBE NEWSWIRE) — Golden Minerals Company (NYSE American and TSX: AUMN) (“Golden Minerals”, “Golden” or “the Company”) announced today that it has entered into an underwriting agreement with H.C. Wainwright & Co. under which the underwriter has agreed to purchase on a firm commitment basis 15,476,191 shares of common stock of the Company, at a price to the public of $0.42 per share, less customary underwriting discounts and commissions. The closing of the offering is expected to occur on or about July 23, 2020, subject to satisfaction of customary closing conditions.H.C. Wainwright & Co. is acting as the sole book-running manager for the offering.The Company also has granted to the underwriter a 30-day option to purchase up to an additional 2,321,428 shares of common stock at the public offering...

MALVERN, Pa., July 21, 2020 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies to treat rare and underserved ophthalmic diseases, today announced it will present at the World Orphan Drug Congress USA 2020 Conference, to be held virtually from August 24-27, 2020.Rasappa Arumugham, PhD, Chief Scientific Officer of Ocugen, will highlight Ocugen’s breakthrough modifier gene therapy platform as part of the Next Generation Therapies Seminar.Presentation Details:Date: Monday, August 24, 2020Time: 1:00 PM (Eastern Time)Website: https://www.terrapinn.com/conference/world-orphan-drug-congress-usa/index.stmAbout Ocugen, Inc.Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing transformative...

CALGARY, Alberta, July 21, 2020 (GLOBE NEWSWIRE) — Parkland Corporation (“Parkland”) (TSX:PKI) expects to announce its 2020 second quarter results after markets close on Thursday, August 6, 2020. A conference call and webcast will then be held at 6:30 a.m. MDT (8:30 a.m. EDT) on Friday, August 7, 2020, to discuss the results. To listen to the live webcast and watch the presentation, please use the following link:https://produceredition.webcasts.com/starthere.jsp?ei=1345078&tp_key=a86f827043Analysts and institutional investors interested in participating in the question and answer session of the conference call may do so by calling 1-888-390-0546 (toll-free) (Conference ID: 51995975).Please connect and log in approximately 10 minutes before the beginning of the call. The webcast will be available for replay two hours after the...

Pretax income of $4.6 millionNet income of $3.0 million, or $0.13 per diluted shareNew contract purchases of $136 millionPretax charges of $12.6 million related to potential losses from the pandemicLAS VEGAS, July 21, 2020 (GLOBE NEWSWIRE) — Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) today announced earnings of $3.0 million, or $0.13 per diluted share, for its second quarter ended June 30, 2020. This compares to net income of $1.8 million, or $0.08 per diluted share, in the second quarter of 2019.Revenues for the second quarter of 2020 were $67.3 million, a decrease of $19.0 million, or 22.0%, compared to $86.3 million for the second quarter of 2019.  Total operating expenses for the second quarter of 2020 were $62.6 million compared to $83.6 million for the 2019 period for a decrease of $20.9 million,...

BOISE, Idaho, July 21, 2020 (GLOBE NEWSWIRE) — Albertsons Companies, Inc. (NYSE: ACI) announced today that it has entered into a tentative agreement with the trustees of the United Food and Commercial Workers International Union (“UFCW”) Union-Industry Pension Fund (“National Fund”), providing that ACI will permanently cease to have any obligation to contribute to the National Fund, a multiemployer pension plan, and will completely withdraw from the National Fund, effective as of June 30, 2020. ACI and the UFCW local unions have entered into a Memorandum of Understanding (MOU) that will instead establish a Variable Annuity Pension Plan (the “VAPP”), effective as of July 1, 2020, providing for future security and service benefits for ACI associates. This agreement will need to be ratified by the membership of each of these unions before...

Revenue of $839 million in Q2’20 grew 49% from Q2’19Q2’20 GAAP earnings per share grew 91% and Non-GAAP earnings per share grew 102% from Q2’19Test revenue grew 59% from Q2’19 on Semiconductor Test strengthIndustrial Automation revenue declined 21% from Q2’19 on global manufacturing weaknessQ3’20 Revenue guidance at mid-point represents 33% growth from Q3’19NORTH READING, Mass., July 21, 2020 (GLOBE NEWSWIRE) — Teradyne, Inc. (NASDAQ: TER) reported revenue of $839 million for the second quarter of 2020 of which $659 million was in Semiconductor Test, $72 million in System Test, $49 million in Wireless Test and $59 million in Industrial Automation (IA). GAAP net income for the second quarter was $188.9 million or $1.05 per diluted share. On a non-GAAP basis, Teradyne’s net income in the second quarter was $229.2 million, or $1.33...